Best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema

被引：84
作者：
Armer J.M. [1 ]
Hulett J.M. [1 ]
Bernas M. [2 ]
Ostby P. [1 ]
Stewart B.R. [1 ,3 ]
Cormier J.N. [4 ]
机构：
[1] Sinclair School of Nursing, Ellis Fischel Cancer Center, University of Missouri-Columbia, Columbia
[2] Department of Surgery, University of Arizona, Tucson, AZ
[3] College of Education, University of Missouri-Columbia, Columbia
[4] Department of Surgical Oncology, University of Texas, MD Anderson Cancer Center, Houston, TX
来源：
Current Breast Cancer Reports | 2013年 / 5卷 / 2期
关键词：
Breast cancer; Combined decongestive therapy; Complementary; Compression garment; Exercise; Intermittent pneumatic compression pump; Limb volume; Lymphatic; Lymphedema; Management; Manual lymphatic drainage; Practices; Risk reduction; Surveillance;
D O I：
10.1007/s12609-013-0105-0
中图分类号：
学科分类号：
摘要：
Breast cancer-related lymphedema (LE) is a progressive, chronic disease that affects millions of cancer survivors and primarily results from surgical lymphatic vessel and/or node removal and radiation therapy. Patient support and education in the importance of early detection is essential in helping health care providers detect lymphedema early, when there is the best chance of preventing progression. Improved imaging and surgical techniques have reduced the incidence of LE; however, effective risk-reduction and treatment have historically lacked the level of evidence necessary to standardize effective treatment. The purpose of this article is to report an extensive review of literature, including highlighted multidisciplinary studies within the past 3 years, in order to update best-practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. © 2013 Springer Science+Business Media New York.
引用
收藏
页码：134 / 144
页数：10
相关论文
共 89 条
[1]  
The Global Economic Cost of Cancer
[2]  
Rockson S.G., Rivera K.K., Estimating the population burden of lymphedema, Ann N y Acad Sci, 1131, pp. 147-154, (2008)
[3]  
Armer J.M., Stewart B.R., Post-breast cancer lymphedema: Incidence increases from 12 to 30 to 60 months, Lymphology, 43, pp. 118-127, (2010)
[4]  
Foldi M., Foldi E., Kubik S., Textbook of Lymphology: For Physicians and Lymphedema Therapists, (2003)
[5]  
Hayes S., Di Sipio T., Rye S., Et al., Prevalence and prognostic significance of secondary lymphedema following breast cancer, Lymphat Res Biol, 9, 3, pp. 135-141, (2011)
[6]  
Bernas M., Askew R., Armer J., Cormier J., Lymphedema: How do we diagnose and reduce the risk of this dreaded complication of breast cancer treatment?, Curr Breast Cancer Rep, 2, 1, pp. 53-58, (2010)
[7]  
Mahamaneerat W.K., Shyu C.-R., Stewart B.R., Armer J.M., Breast cancer treatment, BMI, post-op swelling/lymphoedema, J Lymphoedema, 3, 2, pp. 38-44, (2008)
[8]  
Armer J.M., Stewart B.R., Wanchai A., Et al., Rehabilitation concepts among aging survivors living with and at risk for lymphedema: A framework for assessment, enhancing strengths, and minimizing vulnerability, Top Geriatr Rehabil, 28, 4, pp. 260-268, (2012)
[9]  
Bellury L.M., Ellington L., Beck S.L., Et al., Elderly cancer survivorship: An integrative review and conceptual framework, Eur J Oncol Nurs, 15, pp. 233-242, (2011)
[10]  
Modi S., Stanton A.W.B., Mortimer P.S., Levick J.R., Clinical assessment of human lymph flow using removal rate constants of interstitial macromolecules: A critical review of lymphoscintigraphy, Lymphat Res Biol, 5, 3, pp. 183-202, (2007)
123456789